Novartis Investigative Site

Seongnam Gyeonggi 463-712

1 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer

Studies at this site

• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling